Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2006);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;9.892;Q1;210;17;77;2900;1841;77;25.79;170.59;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;8.345;Q1;241;37;80;8836;1643;77;18.47;238.81;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;7.332;Q1;348;162;916;7271;5709;265;5.54;44.88;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;6.223;Q1;66;8;44;1340;536;44;8.67;167.5;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.402;Q1;225;104;356;5460;3623;324;10.41;52.5;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
6;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.18;Q1;211;134;202;30111;2005;198;9.43;224.71;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;2.857;Q1;233;259;782;24663;4158;776;5.07;95.22;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;2.803;Q1;139;98;308;4299;2070;279;7.36;43.87;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
9;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;2.778;Q1;331;107;365;10459;3297;303;8.44;97.75;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
10;26371;Natural Product Reports;journal;02650568, 14604752;2.753;Q1;188;53;128;9245;949;123;7.73;174.43;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
11;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;2.724;Q1;227;285;762;16343;4724;734;6.23;57.34;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
12;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.697;Q1;146;116;311;5708;1673;293;5.27;49.21;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
13;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.656;Q1;96;44;141;7238;978;136;6.29;164.5;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
14;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.62;Q1;134;24;83;4024;772;83;8.54;167.67;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.616;Q1;190;167;562;6085;2879;529;5.11;36.44;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.548;Q1;202;457;1136;17805;6404;1133;5.37;38.96;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
17;18148;Pain;journal;18726623, 03043959;2.495;Q1;269;292;1010;10938;6071;899;5.52;37.46;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
18;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.412;Q1;195;137;418;4908;2911;325;7.25;35.82;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
19;12611;Drug Resistance Updates;journal;13687646, 15322084;2.412;Q1;119;19;92;2342;572;86;6.27;123.26;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;145164;Human Genomics;journal;14739542, 14797364;2.394;Q1;59;33;65;1350;245;61;3.81;40.91;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1)"
21;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.339;Q1;269;714;2401;20925;11709;2303;4.77;29.31;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.279;Q1;43;22;63;163;281;63;5.31;7.41;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
23;12455;Molecular Therapy;journal;15250024, 15250016;2.219;Q1;185;229;724;9624;3917;649;5.64;42.03;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Molecular Biology (Q2)"
24;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.994;-;144;101;305;3820;2082;296;7.17;37.82;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
25;5100155080;Neurotherapeutics;journal;19337213;1.932;Q1;122;53;109;4821;635;98;5.83;90.96;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
26;20435;Neuropharmacology;journal;00283908, 18737064;1.921;Q1;176;229;730;10800;3136;727;4.33;47.16;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
27;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;1.919;Q1;276;866;2233;35928;13601;2232;6.05;41.49;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
28;21782;Psychopharmacology;journal;00333158, 14322072;1.892;Q1;202;366;1156;19456;4959;1107;4.13;53.16;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
29;26380;Drug and Alcohol Dependence;journal;03768716;1.854;Q1;173;210;463;8779;1918;452;3.86;41.8;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
30;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.847;Q1;183;249;597;33893;3471;562;5.57;136.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
31;20663;Current Drug Metabolism;journal;18755453, 13892002;1.835;Q1;111;65;123;7593;855;117;6.88;116.82;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
32;29099;Cancer Chemotherapy and Pharmacology, Supplement;journal;09439404;1.826;Q1;33;0;14;0;56;14;0;0;Germany;Western Europe;Springer Verlag;1994, 1996-2003;"Cancer Research (Q1); Oncology (Q1); Pharmacology (Q1)"
33;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;1.82;Q1;90;55;146;8234;696;136;4.59;149.71;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
34;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.801;Q1;166;390;915;45398;4931;805;5.54;116.41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
35;21790;Antiviral Therapy;journal;20402058, 13596535;1.79;Q1;89;126;326;4438;1412;312;4.45;35.22;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
36;23010;Journal of Controlled Release;journal;18734995, 01683659;1.788;Q1;282;340;996;11303;4842;992;4.37;33.24;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
37;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.777;Q1;113;95;201;3483;854;169;4.22;36.66;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
38;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;1.771;Q1;203;485;1381;11635;5628;1169;4.06;23.99;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
39;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.761;Q1;115;192;283;9438;1187;281;3.72;49.16;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
40;110112;Journal of Immunotherapy;journal;15249557, 15374513;1.724;Q1;97;63;160;2851;750;154;4.98;45.25;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2)"
41;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.72;Q1;177;212;560;7363;2537;556;4.32;34.73;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
42;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.719;Q1;76;13;36;1808;249;36;6.09;139.08;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
43;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.706;Q1;233;649;1851;24271;9018;1847;4.55;37.4;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
44;23916;Environmental Pollution;journal;02697491, 18736424;1.679;Q1;249;433;890;16737;2995;882;3.09;38.65;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
45;26795;Controlled Clinical Trials;journal;01972456;1.648;Q1;74;0;117;0;404;106;4.3;0;Netherlands;Western Europe;Elsevier BV;1980-2004;Pharmacology (Q1)
46;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.589;Q1;223;397;1331;18137;5236;1293;4.02;45.69;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
47;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.571;Q1;100;46;88;3653;515;87;5.57;79.41;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
48;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.554;Q1;122;151;369;15275;1767;328;4.27;101.16;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
49;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.537;Q1;117;29;69;4381;315;63;3.76;151.07;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
50;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.534;Q1;169;82;241;5255;1515;238;5.36;64.09;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
51;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.533;Q1;206;319;1357;16908;5608;1310;4.04;53;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
52;26512;Tetrahedron;journal;14645416, 00404020;1.524;Q1;226;1309;3497;60611;10455;3480;2.95;46.3;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
53;20664;Current Drug Targets;journal;18735592, 13894501;1.512;Q1;107;161;224;19288;981;205;4.34;119.8;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
54;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.511;Q1;96;55;176;1629;526;174;2.77;29.62;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
55;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.49;Q1;120;340;810;10059;1606;507;1.65;29.59;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
56;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.49;Q1;182;281;683;8936;3346;672;4.41;31.8;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
57;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.464;Q1;100;47;137;4962;584;131;4.14;105.57;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
58;4400151524;Particle and Fibre Toxicology;journal;17438977;1.458;Q1;105;16;14;852;74;13;5.29;53.25;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
59;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.446;Q1;89;24;48;3594;210;45;3.97;149.75;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
60;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.404;Q1;81;67;245;3875;1237;229;5.38;57.84;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
61;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.398;Q1;175;273;803;12287;3389;788;4.3;45.01;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
62;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.382;Q1;118;91;258;4338;982;256;3.99;47.67;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
63;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.377;Q1;134;225;478;10311;1825;467;3.17;45.83;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
64;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.357;Q1;90;54;158;2304;668;139;4.69;42.67;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
65;21237;Drug Safety;journal;01145916, 11791942;1.352;Q1;131;93;262;5283;1192;245;4.51;56.81;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
66;20083;British Journal of Clinical Pharmacology, Supplement;journal;02643774;1.331;Q1;32;0;18;0;60;17;1;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1998, 2000-2004;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
67;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.329;Q1;159;239;838;11543;2779;829;3.22;48.3;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
68;25218;Toxicological Sciences;journal;10960929, 10966080;1.327;Q1;193;333;894;14700;3421;860;3.8;44.14;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
69;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.319;Q1;72;47;169;1326;419;169;2.2;28.21;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Immunology (Q2); Microbiology (Q2)"
70;26514;Tetrahedron Letters;journal;00404039, 18733581;1.314;Q1;173;1965;6158;57964;16655;6157;2.66;29.5;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
71;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.313;Q1;168;131;384;3603;1345;377;3.81;27.5;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
72;18005;American Journal of Respiratory Medicine;journal;11756365;1.279;Q1;32;0;42;0;167;42;0;0;United Kingdom;Western Europe;Adis International Ltd;2002-2003;"Pharmacology (Q1); Pulmonary and Respiratory Medicine (Q1)"
73;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.268;Q1;94;84;204;7122;649;195;3.06;84.79;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
74;22072;Current Gene Therapy;journal;18755631, 15665232;1.267;Q1;75;46;138;6424;605;134;4.41;139.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
75;21196;Drug Discovery Today;journal;18785832, 13596446;1.251;Q1;185;161;853;7603;3045;679;3.54;47.22;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
76;20104;CNS Drug Reviews;journal;1080563X, 15273458;1.246;Q1;61;18;72;1570;251;70;2.9;87.22;United States;Northern America;Neva Press, Inc.;1995-2007;"Pharmacology (Q1); Neuropsychology and Physiological Psychology (Q2)"
77;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.244;Q1;163;208;610;9445;2220;604;3.54;45.41;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
78;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.242;Q1;94;135;418;5844;1751;415;4.21;43.29;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
79;23155;Current Vascular Pharmacology;journal;15701611, 18756212;1.222;Q1;63;37;112;4751;418;109;4.04;128.41;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
80;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1.209;Q1;51;0;172;0;614;159;3.58;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2)"
81;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.207;Q1;129;112;336;4124;892;323;2.17;36.82;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
82;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;1.205;Q1;48;10;17;1137;75;17;4.41;113.7;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Toxicology (Q1); Cancer Research (Q2)"
83;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.197;Q1;83;75;214;3638;563;205;2.45;48.51;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
84;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.197;Q1;213;280;808;11542;3050;803;3.53;41.22;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
85;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.185;Q1;140;195;616;7159;2376;547;3.64;36.71;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
86;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.183;Q1;121;144;275;6477;831;238;3.02;44.98;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
87;23053;Journal of Natural Products;journal;01633864, 15206025;1.162;Q1;147;395;1195;9805;3296;1190;2.72;24.82;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
88;29682;Receptors and Channels;journal;10606823;1.143;Q1;42;0;59;0;166;56;2.53;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2004;"Clinical Biochemistry (Q1); Pharmacology (Q1); Endocrinology (Q2); Cell Biology (Q3)"
89;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1.14;Q1;79;103;218;2841;824;215;3.62;27.58;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2)"
90;19617;Antiviral Research;journal;01663542, 18729096;1.139;Q1;134;118;262;5565;972;260;3.37;47.16;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
91;16088;Journal of Nanobiotechnology;journal;14773155;1.124;Q1;84;14;27;465;106;27;4.33;33.21;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
92;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.12;Q1;79;132;484;7673;1510;446;2.98;58.13;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
93;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.119;Q1;121;153;435;4640;1711;431;3.75;30.33;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
94;24763;Addictive Behaviors;journal;03064603;1.118;Q1;135;228;512;6951;1294;510;2.37;30.49;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
95;22319;Toxicon;journal;18793150, 00410101;1.115;Q1;133;217;706;8412;1816;694;2.63;38.76;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q1)
96;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;1.088;Q1;186;243;781;7812;2382;761;2.9;32.15;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
97;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.075;Q1;109;138;426;11102;1495;414;3.43;80.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
98;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.074;Q1;138;82;119;3749;421;110;3.54;45.72;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
99;22477;Investigational New Drugs;journal;01676997, 15730646;1.068;Q1;90;64;165;2161;573;162;3.25;33.77;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
100;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.06;Q1;189;754;2151;30523;6367;2141;2.84;40.48;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q1)
101;25109;Inhalation Toxicology;journal;08958378, 10917691;1.057;Q1;90;114;259;4099;717;255;2.8;35.96;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
102;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;1.039;Q1;58;58;183;1542;540;174;2.74;26.59;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q1); Molecular Medicine (Q2)"
103;25219;Toxicology;journal;0300483X, 18793185;1.034;Q1;165;311;823;12263;2833;810;3.13;39.43;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q1)
104;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.032;Q1;70;35;110;1339;410;102;2.81;38.26;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Genetics (Q3); Molecular Biology (Q3)"
105;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.03;Q1;95;49;109;2401;262;108;1.81;49;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
106;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.029;Q1;115;156;404;6303;782;404;1.64;40.4;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
107;25240;Toxicology Letters;journal;03784274, 18793169;1.018;Q1;150;241;752;8608;2444;733;3.14;35.72;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
108;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.01;Q1;133;514;1306;13304;3002;1302;2.24;25.88;Netherlands;Western Europe;Elsevier;1983-2022;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Spectroscopy (Q2)"
109;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1;Q1;88;60;145;4656;445;129;2.98;77.6;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
110;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;0.995;Q1;229;530;1272;15059;3689;1260;2.74;28.41;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
111;21169;Pharmacological Research;journal;10436618, 10961186;0.992;Q1;147;137;455;5965;1440;450;3.24;43.54;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
112;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.99;Q1;154;1247;3166;29814;8974;3163;2.79;23.91;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Molecular Medicine (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
113;18071;Neurotoxicity Research;journal;14763524, 10298428;0.99;Q1;78;55;170;3615;535;167;3.23;65.73;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
114;18073;NeuroToxicology;journal;18729711, 0161813X;0.978;Q1;122;136;283;6124;847;278;3.05;45.03;Netherlands;Western Europe;Elsevier;1979-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
115;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;0.975;Q1;95;141;272;11742;941;257;3.59;83.28;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Drug Discovery (Q2)"
116;21687;American Journal of PharmacoGenomics;journal;11752203;0.965;Q2;38;0;114;0;413;112;3.55;0;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
117;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.965;Q1;55;27;95;3047;276;88;2.66;112.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Microbiology (medical) (Q2); Molecular Medicine (Q3)"
118;25075;Ecotoxicology;journal;09639292, 15733017;0.963;Q1;97;68;181;2302;326;174;1.42;33.85;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
119;18966;Mutagenesis;journal;02678357, 14643804;0.947;Q1;95;56;205;2367;587;201;2.52;42.27;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q3); Genetics (clinical) (Q3)"
120;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.945;Q2;102;152;443;4004;1002;434;2.18;26.34;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q2)"
121;20473;Life Sciences;journal;18790631, 00243205;0.94;Q1;174;701;1642;27392;4907;1640;2.72;39.08;United States;Northern America;Elsevier Inc.;1962-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
122;21167;Pharmacogenomics;journal;14622416, 17448042;0.939;Q2;94;115;282;4762;847;244;3.37;41.41;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
123;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;0.929;Q2;139;257;816;13069;2016;813;2.39;50.85;United States;Northern America;Elsevier Inc.;1973-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Pharmacology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3); Biological Psychiatry (Q3)"
124;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.928;Q1;171;827;1807;29433;5106;1804;2.9;35.59;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
125;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;0.924;Q2;205;407;1042;12847;2580;1033;2.23;31.57;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
126;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;0.91;Q2;91;118;426;10116;1348;420;3.23;85.73;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2)"
127;16948;Chirality;journal;1520636X, 08990042;0.908;Q2;80;110;346;3419;837;340;2.36;31.08;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
128;20680;Current Opinion in Molecular Therapeutics;journal;14648431;0.908;Q2;66;69;270;3935;692;241;2.53;57.03;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
129;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.9;Q2;85;263;868;8878;1505;866;1.67;33.76;United States;Northern America;Wiley-Blackwell;1918-2021;"Biochemistry (Q2); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
130;21165;PharmacoEconomics;journal;11707690, 11792027;0.898;Q2;104;137;334;5024;935;307;2.55;36.67;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Public Health, Environmental and Occupational Health (Q1); Pharmacology (Q2)"
131;21744;Planta Medica;journal;14390221, 00320943;0.896;Q1;122;260;769;5554;1713;761;2.01;21.36;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
132;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.889;Q2;96;150;365;3925;1101;348;3.06;26.17;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
133;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.884;Q2;183;230;558;9464;1675;548;2.91;41.15;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
134;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;0.879;Q2;153;207;632;5596;1877;534;2.92;27.03;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
135;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.872;Q2;103;115;280;4082;698;268;2.51;35.5;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q2); Toxicology (Q2)"
136;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.867;Q2;87;172;598;6880;1411;586;2.44;40;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
137;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.859;Q2;66;86;240;3935;703;220;2.99;45.76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q1); Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2)"
138;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;0.858;Q2;114;222;488;6029;1369;488;2.85;27.16;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (medical) (Q1); Oncology (Q2); Pharmacology (Q2); Toxicology (Q2); Cancer Research (Q3)"
139;25093;Environmental Toxicology;journal;15227278, 15204081;0.853;Q2;81;78;206;2771;393;204;1.7;35.53;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
140;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;0.849;Q1;66;0;261;0;773;254;3.14;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
141;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;0.849;Q2;36;8;23;1253;65;20;2.53;156.63;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q2); Molecular Medicine (Q3)"
142;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.848;Q2;66;33;127;1088;234;124;2.12;32.97;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
143;14805;Steroids;journal;0039128X, 18785867;0.848;Q2;107;141;356;4434;1155;356;3.12;31.45;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
144;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.84;Q2;76;54;146;2468;313;143;2.12;45.7;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q2); Physiology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
145;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;0.828;Q2;78;117;346;2315;599;330;1.58;19.79;United States;Northern America;Preston Publications;1977-2021;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
146;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.822;Q2;92;141;427;5564;917;419;1.94;39.46;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
147;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.818;Q2;42;25;112;3028;289;104;2.57;121.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
148;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.815;Q2;103;70;217;3823;600;209;2.5;54.61;United States;Northern America;Elsevier Inc.;1987-2021;"Developmental Neuroscience (Q2); Toxicology (Q2); Cellular and Molecular Neuroscience (Q4)"
149;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.811;Q2;96;153;409;5742;1077;406;2.79;37.53;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
150;20783;Expert Review of Vaccines;journal;14760584, 17448395;0.81;Q2;91;76;265;6009;677;243;2.24;79.07;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q2); Pharmacology (Q2); Immunology (Q3); Molecular Medicine (Q3)"
151;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.801;Q2;80;62;201;1823;585;184;3.08;29.4;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Neurology (clinical) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
152;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.79;Q2;90;105;194;4028;395;193;1.97;38.36;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
153;20051;BioDrugs;journal;11738804, 1179190X;0.786;Q2;71;42;125;2488;379;123;3.66;59.24;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Biotechnology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
154;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;0.781;Q1;144;150;573;5709;1407;568;2.18;38.06;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
155;25898;Journal of Peptide Science;journal;10752617, 10991387;0.775;Q2;68;110;248;3484;494;239;1.84;31.67;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
156;24028;Reproductive Toxicology;journal;08906238, 18731708;0.769;Q2;117;155;263;7243;673;246;2.64;46.73;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q2)
157;22432;International Immunopharmacology;journal;18781705, 15675769;0.768;Q2;119;243;551;8584;1354;547;2.41;35.33;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
158;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;0.767;Q2;93;94;386;4860;1005;382;3.01;51.7;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
159;17067;Phytomedicine;journal;09447113, 1618095X;0.758;Q1;127;129;326;3506;729;317;1.96;27.18;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
160;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.757;Q2;63;68;264;2230;489;256;1.91;32.79;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q1); Oncology (Q2); Pharmacology (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3)"
161;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;0.756;Q2;71;56;186;2148;328;159;1.44;38.36;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
162;20027;BMC Pharmacology;journal;14712210;0.755;Q2;44;14;65;494;160;65;2.35;35.29;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
163;24749;Addiction Biology;journal;13556215, 13691600;0.754;Q2;83;33;132;2367;252;120;2;71.73;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
164;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;0.754;Q2;113;137;371;6759;841;369;2.19;49.34;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Physiology (Q2); Toxicology (Q2); Biochemistry (Q3); Cell Biology (Q3)"
165;21229;Drug News and Perspectives;journal;02140934;0.747;Q2;51;80;249;3363;473;248;1.7;42.04;Spain;Western Europe;Prous Science;1990-2010;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
166;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.744;Q2;175;176;391;5052;1084;391;2.53;28.7;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
167;29053;Molecular Diversity;journal;1573501X, 13811991;0.739;Q2;58;55;160;2825;386;153;2.11;51.36;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3); Molecular Biology (Q3)"
168;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.737;Q2;40;29;91;4161;231;91;2.41;143.48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
169;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.733;Q2;77;61;233;2803;620;231;2.36;45.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
170;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.73;Q2;104;200;823;7495;1594;821;1.87;37.48;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
171;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.727;Q1;95;78;194;3224;458;184;2.22;41.33;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
172;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.725;Q1;65;38;117;1144;356;112;3.14;30.11;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Electrical and Electronic Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Nanoscience and Nanotechnology (Q3)"
173;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.717;Q2;112;83;232;3698;513;212;2.06;44.55;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
174;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.713;Q2;38;23;83;967;180;83;1.85;42.04;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
175;24652;Chemico-Biological Interactions;journal;00092797;0.71;Q2;128;138;413;6896;855;409;1.8;49.97;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
176;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.708;Q2;51;46;116;5338;326;116;3.05;116.04;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
177;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.705;Q2;87;142;410;7065;687;403;1.51;49.75;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (medical) (Q2); Physiology (Q3)"
178;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.699;Q2;52;35;132;1435;203;118;1.52;41;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
179;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.697;Q2;64;42;82;1464;170;81;1.56;34.86;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
180;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.697;Q2;114;178;459;5377;1187;421;2.33;30.21;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
181;25224;Toxicology in Vitro;journal;18793177, 08872333;0.696;Q2;112;180;326;7191;840;325;2.43;39.95;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
182;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.695;Q2;107;206;510;8842;993;501;1.84;42.92;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
183;22318;Toxicological Reviews;journal;11762551;0.695;Q2;46;20;75;2097;177;67;1.69;104.85;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
184;23942;Biomedical Chromatography;journal;10990801, 02693879;0.694;Q2;68;179;310;4623;539;308;1.7;25.83;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
185;25214;Toxicologic Pathology;journal;15331601, 01926233;0.694;Q2;112;96;332;4303;683;310;2.14;44.82;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
186;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.691;Q2;63;95;252;2415;527;229;2.25;25.42;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
187;15840;Journal of Antibiotics;journal;00218820, 18811469;0.69;Q2;84;107;365;1814;453;330;1.24;16.95;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
188;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.686;Q2;56;18;97;848;195;95;1.7;47.11;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
189;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;0.686;Q1;69;61;161;843;405;161;2.65;13.82;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
190;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.685;Q2;54;30;103;1206;228;102;2.29;40.2;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Pharmacology (Q2); Virology (Q3)"
191;24578;Mathematical Medicine and Biology;journal;14778599;0.684;Q2;46;19;52;664;91;51;1.42;34.95;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Environmental Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Neuroscience (miscellaneous) (Q3)"
192;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.683;Q2;104;56;186;2701;606;186;2.64;48.23;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
193;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;0.682;Q2;50;21;73;1607;154;73;2.06;76.52;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
194;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.68;Q2;75;61;125;2253;309;118;2.47;36.93;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
195;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.675;Q2;74;62;225;2192;489;223;2.25;35.35;United States;Northern America;Wiley-Blackwell;1986-2021;"Medicine (miscellaneous) (Q1); Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Drug Discovery (Q2); Process Chemistry and Technology (Q2); Molecular Medicine (Q3)"
196;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.675;Q2;62;44;138;1704;267;138;1.49;38.73;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
197;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.675;Q2;62;81;211;2383;319;204;1.51;29.42;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Veterinary (miscellaneous) (Q1); Pharmacology (Q2)"
198;24604;Archives of Toxicology;journal;14320738, 03405761;0.674;Q2;121;108;276;3596;554;271;1.85;33.3;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
199;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.669;Q2;88;97;293;4021;487;292;1.34;41.45;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Pharmacology (Q2); Toxicology (Q2)"
200;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.667;Q2;109;111;376;4432;876;361;2.07;39.93;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
201;23412;Journal of AOAC International;journal;10603271;0.656;Q2;90;216;607;5848;966;597;1.57;27.07;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
202;24785;Alcohol;journal;07418329;0.655;Q2;83;69;222;2893;491;214;2.37;41.93;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2); Biochemistry (Q3); Neurology (Q3); Behavioral Neuroscience (Q4)"
203;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.651;Q1;122;499;1278;14336;2341;1273;1.78;28.73;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
204;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.647;Q2;53;92;245;4416;565;243;2.29;48;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
205;144771;Clinical Trials;journal;17407753, 17407745;0.645;Q2;67;46;131;1352;153;118;1.17;29.39;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
206;22378;Vascular Pharmacology;journal;18793649, 15371891;0.644;Q2;100;112;155;5564;295;151;1.96;49.68;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Molecular Medicine (Q3); Physiology (Q3)"
207;23009;Journal of Clinical Research;journal;13695207;0.64;Q2;11;2;7;85;13;7;2.6;42.5;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
208;16067;Reading Teacher;journal;00340561;0.64;Q2;53;79;231;1738;116;227;0.41;22;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
209;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;0.632;Q1;66;101;296;2244;383;189;1.31;22.22;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
210;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.628;Q2;98;219;689;7334;1257;684;1.84;33.49;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
211;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.624;Q2;81;206;327;7939;721;326;2.16;38.54;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
212;18077;Fitoterapia;journal;0367326X, 18736971;0.618;Q2;110;138;435;2139;642;434;1.24;15.5;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
213;21825;Reviews in Contemporary Pharmacotherapy;journal;09548602;0.615;Q2;17;0;2;0;4;2;3;0;United Kingdom;Western Europe;Marius Press;1996-2004;Pharmacology (Q2)
214;22410;Inflammation Research;journal;1420908X, 10233830;0.603;Q2;94;123;409;3484;695;403;1.67;28.33;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
215;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.599;Q2;99;393;1249;6961;1465;744;1.23;17.71;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
216;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.597;Q1;81;39;142;1318;359;139;1.9;33.79;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
217;16533;Phytochemical Analysis;journal;09580344, 10991565;0.597;Q2;76;65;195;1254;275;195;1.32;19.29;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
218;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.595;Q1;73;58;105;1805;251;100;2.61;31.12;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
219;110172;Progress in Drug Research;book series;0071786X;0.594;Q1;44;0;48;0;87;43;1.09;0;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
220;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.591;Q2;21;7;21;254;44;20;2.13;36.29;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Pharmacology (Q2); Immunology (Q3)"
221;144790;Marine Drugs;journal;16603397;0.589;Q2;128;18;39;1338;70;36;1.97;74.33;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q2)
222;84948;Expert Opinion on Drug Delivery;journal;17425247;0.588;Q1;116;65;97;5359;206;93;2.12;82.45;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
223;16573;Phytotherapy Research;journal;10991573, 0951418X;0.588;Q2;140;204;678;5568;1216;675;1.54;27.29;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
224;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.57;Q2;93;165;342;5935;683;329;1.93;35.97;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
225;21207;Drug Discovery Today: Technologies;journal;17406749;0.568;Q2;53;59;117;1964;272;111;2.32;33.29;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Drug Discovery (Q2); Biotechnology (Q3); Molecular Medicine (Q3)"
226;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.565;Q2;83;226;676;15502;1507;663;2.24;68.59;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
227;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.564;Q1;124;207;618;7680;1146;612;1.81;37.1;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
228;25864;Heterocycles;journal;03855414;0.559;Q2;66;417;1032;11955;1139;1025;1.12;28.67;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Analytical Chemistry (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
229;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.559;Q3;78;49;133;1620;262;130;1.93;33.06;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3); Physiology (Q3)"
230;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.558;Q3;95;372;1018;7807;1509;1018;1.44;20.99;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
231;20570;Chemotherapy;journal;00093157, 14219794;0.556;Q3;58;52;210;1160;332;204;1.62;22.31;Switzerland;Western Europe;S. Karger AG;1960-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
232;19900192900;Molecular Informatics;journal;18681751, 18681743;0.554;Q3;70;99;236;3876;646;229;2.46;39.15;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q2); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Structural Biology (Q4)"
233;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.543;Q3;90;119;335;2962;422;332;1.13;24.89;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
234;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.54;Q3;52;67;195;1234;216;188;1.1;18.42;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
235;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.536;Q3;58;115;236;3611;546;222;2.55;31.4;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
236;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.536;Q2;91;69;200;2731;390;191;1.83;39.58;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
237;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.534;Q3;69;97;291;2340;458;281;1.56;24.12;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
238;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.525;Q3;64;63;175;1847;245;173;1.35;29.32;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
239;14990;Current Neuropharmacology;journal;18756190, 1570159X;0.515;Q3;82;28;55;3460;54;52;0.98;123.57;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
240;14822;Xenobiotica;journal;00498254, 13665928;0.512;Q3;82;71;242;3596;473;242;1.92;50.65;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
241;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.508;Q3;79;101;229;3310;421;227;1.75;32.77;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
242;130025;Current Drug Delivery;journal;15672018;0.498;Q1;65;46;83;3115;181;82;2.18;67.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
243;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.496;Q2;81;73;199;1674;265;198;0.95;22.93;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Colloid and Surface Chemistry (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
244;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.486;Q3;52;32;108;2041;229;103;1.94;63.78;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Developmental Biology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
245;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.48;Q2;42;118;180;1483;172;180;0.78;12.57;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
246;13671;Biologicals;journal;10958320, 10451056;0.478;Q3;60;50;118;991;137;113;0.92;19.82;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
247;20026;BMC Clinical Pharmacology;journal;14726904;0.476;Q3;39;8;16;246;38;16;2.17;30.75;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
248;4000150314;Chemical Biology and Drug Design;journal;17470277;0.47;-;82;101;271;3117;398;266;1.47;30.86;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q4)"
249;21194;Pharmacology;journal;00317012, 14230313;0.469;Q3;60;73;263;2470;390;263;1.43;33.84;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
250;19374;AAPS PharmSciTech;journal;15309932;0.461;Q2;101;100;227;2283;312;213;1.14;22.83;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Agronomy and Crop Science (Q2); Ecology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Aquatic Science (Q3); Drug Discovery (Q3); Ecology, Evolution, Behavior and Systematics (Q3)"
251;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.458;Q2;51;213;675;4836;579;670;0.9;22.7;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
252;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.456;Q3;24;28;47;3662;80;43;1.7;130.79;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
253;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.456;Q3;77;117;362;7106;489;350;1.52;60.74;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
254;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.455;Q3;64;31;81;995;116;76;1.12;32.1;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q3)
255;20770;Drug Delivery;journal;10717544, 15210464;0.451;Q2;72;51;131;1463;197;131;1.67;28.69;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
256;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.448;Q1;91;193;686;5781;950;681;1.33;29.95;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
257;4000148203;Handbook of Experimental Pharmacology;journal;01712004;0.446;Q1;96;182;156;20658;115;152;0.74;113.51;Germany;Western Europe;Springer Heidelberg;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q3)"
258;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.444;Q3;52;167;400;3355;608;367;1.49;20.09;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
259;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.442;Q3;67;114;375;1427;364;337;0.91;12.52;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
260;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.436;Q2;62;53;146;1340;140;143;0.94;25.28;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
261;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.435;Q3;47;44;79;2503;116;76;1.35;56.89;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
262;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.433;Q3;76;87;230;2306;312;215;1.17;26.51;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
263;27210;In Vivo;journal;17917549, 0258851X;0.432;Q3;64;153;371;3908;518;371;1.52;25.54;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
264;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.43;Q3;76;267;1022;4549;746;1018;0.59;17.04;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
265;130047;Current Drug Discovery Technologies;journal;15701638;0.418;Q3;44;22;46;1460;100;45;2.17;66.36;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q3)
266;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.412;Q3;98;83;317;1846;488;255;1.51;22.24;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
267;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.411;Q3;50;37;111;1616;235;111;2.27;43.68;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Medicine (miscellaneous) (Q2); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q4)"
268;130063;Pharmacological Reports;journal;17341140;0.409;Q3;87;129;366;4474;549;365;1.56;34.68;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
269;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.404;Q2;65;80;208;1909;268;206;1.37;23.86;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
270;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;0.403;Q2;133;36;48;1255;79;40;1.65;34.86;United States;Northern America;Elsevier Inc.;2005-2021;"Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Molecular Medicine (Q4); Nanoscience and Nanotechnology (Q4)"
271;16836;BMC Chemical Biology;journal;14726769;0.4;Q3;20;3;6;90;7;6;1.4;30;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q3); Molecular Medicine (Q4)"
272;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.394;Q3;93;179;623;4800;682;623;1.08;26.82;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
273;26370;Molecules;journal;14203049;0.392;Q2;171;106;361;2663;370;347;0.87;25.12;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Medicine (Q4)"
274;23489;Chemical Speciation and Bioavailability;journal;09542299;0.388;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
275;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.379;Q3;46;35;92;1187;108;92;1.27;33.91;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
276;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.379;Q3;10;0;49;0;18;28;0.37;0;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q3); Organic Chemistry (Q3)"
277;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.378;Q3;39;0;105;0;154;105;1.52;0;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
278;21264;Drugs in R and D;journal;11796901, 11745886;0.377;Q3;47;37;190;1816;241;190;1.47;49.08;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
279;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.371;Q3;39;34;63;499;41;53;0.65;14.68;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
280;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.367;Q2;63;58;226;1291;235;200;1;22.26;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3); Toxicology (Q3)"
281;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.364;Q2;61;50;142;1523;176;142;1.22;30.46;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
282;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.362;Q3;48;113;314;2136;234;313;0.75;18.9;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3); Biochemistry (Q4)"
283;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.359;Q3;29;86;129;3896;117;122;0.91;45.3;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
284;25144;Journal of Health Science;journal;13475207, 13449702;0.358;Q3;49;126;305;3101;260;305;0.85;24.61;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
285;4000148019;AAPS Journal;journal;15507416;0.356;Q2;118;90;188;5555;341;182;1.98;61.72;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q2)
286;21717;Die Pharmazie;journal;00317144;0.353;Q2;66;234;678;4684;589;675;0.8;20.02;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
287;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.351;Q3;50;49;107;1685;85;106;0.76;34.39;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
288;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.346;Q1;23;19;23;696;22;23;1;36.63;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
289;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.345;Q3;53;47;101;1260;115;100;0.99;26.81;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
290;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.343;Q3;64;43;254;1061;211;239;0.31;24.67;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
291;62892;Drug Discovery Today: BIOSILICO;journal;17418364;0.342;Q3;17;0;81;0;125;64;2.07;0;Netherlands;Western Europe;Elsevier BV;2003-2004;Drug Discovery (Q3)
292;4400151608;ChemMedChem;journal;18607187, 18607179;0.341;Q2;106;145;441;5995;561;439;1.18;41.34;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3); Molecular Medicine (Q4)"
293;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.339;Q3;62;58;201;3132;223;179;0.86;54;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
294;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.338;Q2;60;40;106;1059;140;104;1.33;26.48;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
295;18800156720;Dissolution Technologies;journal;1521298X;0.337;Q2;34;19;71;222;34;31;0.45;11.68;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q2)
296;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.337;Q3;70;67;172;2038;194;171;1.18;30.42;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q3); Toxicology (Q3); Cell Biology (Q4)"
297;25106;Human and Experimental Toxicology;journal;09603271;0.337;Q3;82;91;272;3471;363;252;1.28;38.14;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
298;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.336;Q3;53;70;237;4210;267;236;1.14;60.14;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
299;22881;Yaoxue Xuebao;journal;05134870;0.336;Q2;34;228;694;3338;392;692;0.55;14.64;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
300;24659;Comments on Toxicology;journal;08865140;0.335;Q3;12;0;12;0;6;10;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1995-2003;Toxicology (Q3)
301;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.335;Q2;52;70;196;2027;145;195;0.77;28.96;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
302;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.332;Q2;31;0;60;0;81;60;1.1;0;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
303;19441;American Journal of Drug Delivery;journal;11759038;0.329;Q3;22;28;41;1319;35;39;0.85;47.11;United Kingdom;Western Europe;Adis International Ltd;2004-2006;Pharmacology (Q3)
304;21186;Drug Design and Discovery;journal;10559612, 10292322;0.329;Q3;20;0;12;0;16;12;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2003;"Drug Discovery (Q3); Molecular Medicine (Q4)"
305;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.327;Q2;12;0;7;0;9;7;0;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3); Virology (Q3)"
306;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.326;Q3;29;32;79;919;61;67;0.88;28.72;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
307;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.322;Q3;46;70;63;3659;72;63;1.14;52.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q3)
308;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.32;Q3;61;57;340;1745;287;316;0.8;30.61;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Toxicology (Q3)"
309;15340;Developments in Biologicals;journal;14246074, 16622960;0.32;Q3;38;153;239;1709;197;239;0.67;11.17;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Immunology (Q3); Pharmacology (Q3); Biomaterials (Q4)"
310;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.319;Q3;88;69;51;6961;76;51;1.49;100.88;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Toxicology (Q3)"
311;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.314;Q2;66;45;91;1419;80;91;0.68;31.53;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q3)"
312;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.313;Q3;21;66;70;1548;59;70;0.58;23.45;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
313;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.313;Q3;41;24;87;2773;37;27;0.18;115.54;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q4)"
314;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.31;Q2;57;43;124;1131;123;122;1.01;26.3;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
315;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.31;Q2;72;118;388;2997;235;385;0.47;25.4;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
316;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.307;Q3;48;52;108;1134;132;101;1.08;21.81;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4)"
317;21192;Drug Development Research;journal;02724391, 10982299;0.306;Q3;62;98;304;5673;295;298;0.96;57.89;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
318;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.305;Q3;53;56;158;1721;139;156;0.79;30.73;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
319;17700156431;Handbook of Analytical Separations;book series;15677192;0.304;Q2;12;0;29;0;18;1;0.21;0;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Analytical Chemistry (Q3); Pathology and Forensic Medicine (Q3); Environmental Chemistry (Q4)"
320;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.301;Q3;20;66;192;590;140;192;0.77;8.94;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
321;21100470510;Drug Research;journal;21949379, 21949387;0.291;Q3;65;134;378;2966;326;376;0.71;22.13;Germany;Western Europe;Thieme;1972, 2013-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
322;26767;Altex;journal;1868596X, 18688551;0.286;Q3;57;23;100;411;60;96;0.75;17.87;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
323;23039;Journal of Liposome Research;journal;08982104, 15322394;0.281;Q2;53;34;53;1012;65;49;1.28;29.76;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q2)
324;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.28;Q3;36;21;62;709;44;62;0.68;33.76;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Drug Discovery (Q4); Physiology (Q4)"
325;20634;Journal of Texture Studies;journal;00224901, 17454603;0.277;Q2;57;45;106;1177;76;105;0.64;26.16;United States;Northern America;Wiley-Blackwell;1969-2021;"Pharmaceutical Science (Q2); Food Science (Q3)"
326;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.273;Q3;39;34;122;1274;79;117;0.56;37.47;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
327;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.273;Q2;40;42;118;1014;67;95;0.69;24.14;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
328;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.272;Q2;48;286;793;5745;421;793;0.51;20.09;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q4)"
329;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.271;Q4;38;43;100;1610;66;97;0.69;37.44;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Bioengineering (Q3); Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
330;20065;BioPharm International;trade journal;1542166X, 19391862;0.267;Q2;29;120;403;490;79;347;0.21;4.08;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
331;73430;Pharmaceutical Technology;journal;15432521;0.267;Q2;38;163;547;780;124;335;0.21;4.79;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q2); Biophysics (Q3)"
332;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.265;Q2;61;218;496;3975;174;496;0.33;18.23;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
333;21265;Drugs of the Future;journal;03778282;0.257;Q3;45;118;1322;5752;259;331;0.14;48.75;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
334;21211;Pharmacy Education;journal;14772701, 15602214;0.255;Q2;18;35;97;674;39;96;0.25;19.26;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q1); Pharmaceutical Science (Q2); Education (Q3)"
335;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.252;Q2;69;143;332;1786;214;320;0.63;12.49;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Education (Q3)"
336;130007;Drug Design Reviews Online;journal;15672697;0.252;Q2;10;0;48;0;35;48;0.73;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Pharmaceutical Science (Q2); Drug Discovery (Q4); Molecular Medicine (Q4)"
337;35190;Revista Espanola de Quimioterapia;journal;02143429;0.252;Q3;26;51;153;1722;101;136;0.54;33.76;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q2); Microbiology (medical) (Q3); Pharmacology (Q3)"
338;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.251;Q2;9;44;8;1133;5;8;0.63;25.75;United Kingdom;Western Europe;;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
339;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.25;Q2;39;43;98;1125;58;98;0.54;26.16;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacy (Q2); Health Policy (Q3); Public Health, Environmental and Occupational Health (Q3)"
340;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.245;Q3;51;136;280;3073;108;275;0.35;22.6;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
341;21102;Pharmaceutical Journal;journal;00316873;0.245;Q2;28;1077;7669;1200;251;612;0.03;1.11;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
342;24097;Journal of the Indian Chemical Society;journal;00194522;0.244;Q4;33;279;751;5148;265;738;0.34;18.45;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Electrochemistry (Q3); Drug Discovery (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
343;25253;Blutalkohol (discontinued);journal;00065250;0.243;Q3;13;27;95;254;28;90;0.23;9.41;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
344;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.242;Q4;27;74;146;3305;73;134;0.5;44.66;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q4); Molecular Medicine (Q4)"
345;130089;Toxin Reviews;journal;15569543, 15569551;0.242;Q3;46;29;90;1716;84;83;0.96;59.17;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q3)
346;22375;Indian Drugs;journal;0019462X;0.241;Q3;31;125;408;1836;85;408;0.19;14.69;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
347;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.24;Q3;36;10;40;351;47;40;0.97;35.1;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
348;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.24;Q3;14;39;0;4574;0;0;0;117.28;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
349;94084;Drug Discovery Today: TARGETS;journal;17418372;0.239;Q4;15;0;126;0;76;104;0.72;0;Netherlands;Western Europe;Elsevier BV;2002-2004;Drug Discovery (Q4)
350;4400151410;Human Vaccines;journal;15548600, 15548619;0.235;Q3;58;42;39;1231;24;39;0.62;29.31;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Immunology (Q4)"
351;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.231;Q3;62;47;69;1780;65;69;0.92;37.87;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
352;59665;Chinese Journal of Natural Medicines;journal;16723651;0.23;Q4;40;100;178;1195;72;177;0.4;11.95;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
353;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.23;Q4;12;29;69;693;32;69;0.46;23.9;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
354;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.229;Q3;54;33;36;1049;13;31;0.36;31.79;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
355;22411;Inflammopharmacology;journal;09254692, 15685608;0.227;Q3;55;38;134;1467;99;129;0.71;38.61;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3); Immunology (Q4)"
356;130038;Letters in Drug Design and Discovery;journal;15701808;0.227;Q3;35;114;99;4853;71;99;0.72;42.57;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
357;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.226;Q3;19;47;139;452;26;124;0.18;9.62;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q2); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
358;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.225;Q3;24;40;101;3756;67;91;0.66;93.9;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4)"
359;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.225;Q3;19;29;43;639;27;36;0.74;22.03;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
360;20578;Journal of Food and Drug Analysis;journal;10219498;0.221;Q3;63;59;168;1505;65;167;0.36;25.51;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
361;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.221;Q3;10;32;137;212;19;135;0.05;6.63;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
362;73076;Drug Discovery World;journal;14694344;0.22;Q4;13;28;48;243;28;43;0.58;8.68;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
363;79053;Natural Product Sciences;journal;12263907;0.22;Q4;28;47;183;1128;53;183;0.27;24;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
364;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.22;Q3;46;67;131;2826;87;130;0.59;42.18;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
365;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.219;Q3;29;36;65;837;23;64;0.37;23.25;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
366;19446;American Pharmaceutical Review;journal;10998012;0.217;Q3;24;101;261;1423;113;241;0.46;14.09;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
367;22906;Journal of China Pharmaceutical University;journal;10005048;0.217;Q3;14;132;425;1481;124;425;0.3;11.22;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
368;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.217;Q3;19;12;37;122;23;37;0.73;10.17;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q2); Drug Guides (Q3); Pharmacology (Q3)"
369;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.216;Q3;53;65;219;1359;115;184;0.46;20.91;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (medical) (Q3); Physiology (Q4)"
370;25245;Veterinary and Human Toxicology;journal;01456296;0.214;Q4;41;0;214;0;168;203;0.88;0;United States;Northern America;Comparative Toxicology Laboratories;1977-2004;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
371;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.212;Q3;62;124;304;2111;133;194;0.4;17.02;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
372;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.212;Q3;9;30;107;479;22;91;0.12;15.97;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q2); Pharmaceutical Science (Q3); Pharmacology (Q3)"
373;21496;Revista de Chimie (discontinued);journal;00347752;0.212;-;31;279;733;4248;193;732;0.29;15.23;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
374;23284;Acta Physiologica et Pharmacologica Bulgarica;journal;03239950;0.211;Q3;15;0;12;0;14;12;0;0;Bulgaria;Eastern Europe;Universitetsko Izdatelstvo Sv. Kliment Okhridski/Publishing House of the Sofia University St. Kilment Ohridski;1974-1996, 1998-2001, 2003;"Pharmacology (Q3); Physiology (Q4)"
375;13718;Pharmaceutical Engineering;journal;02738139;0.21;Q3;16;61;156;276;21;148;0.14;4.52;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
376;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.208;Q4;40;28;43;1016;32;42;0.74;36.29;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q4); Toxicology (Q4)"
377;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.205;Q4;32;25;71;946;27;69;0.45;37.84;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
378;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.205;Q3;35;177;645;886;316;639;0.51;5.01;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
379;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.205;Q3;33;38;37;1171;17;37;0.46;30.82;United States;Northern America;Begell House Inc.;2005-2021;"Pharmacology (Q3); Applied Microbiology and Biotechnology (Q4); Drug Discovery (Q4)"
380;21127;Pharmaceutical Technology Europe;journal;01646826;0.204;Q3;18;105;268;510;37;156;0.15;4.86;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
381;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.201;Q3;19;220;693;768;57;677;0.09;3.49;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
382;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.193;Q3;9;10;19;257;10;19;0.82;25.7;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q3)
383;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.192;Q3;42;30;171;939;79;158;0.48;31.3;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
384;21758;Prescrire International;journal;11677422;0.191;Q3;13;109;430;1189;107;220;0.32;10.91;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
385;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.189;Q3;50;59;161;1098;51;155;0.33;18.61;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Organic Chemistry (Q4)"
386;21227;Pharmacy in Practice;journal;13581538;0.189;Q3;5;52;198;414;12;165;0.06;7.96;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Health Policy (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Pharmacy (Q3)"
387;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.188;Q3;6;23;78;298;11;66;0.2;12.96;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q3)
388;20661;Current Drug Discovery;journal;14727463;0.188;Q3;12;0;227;0;61;123;0.28;0;United Kingdom;Western Europe;Current Drugs Ltd.;2002-2004;Pharmacology (Q3)
389;21798;Farmaceutski Glasnik;journal;00148202;0.188;Q3;6;16;58;394;6;58;0.13;24.63;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
390;20684;Current Pharmacogenomics;journal;15701603;0.183;Q3;12;33;56;2875;34;56;0.61;87.12;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
391;20564;Ceska a Slovenska Farmacie;journal;12107816;0.182;Q3;17;44;161;1152;54;161;0.3;26.18;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
392;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.181;Q3;15;45;101;418;17;85;0.19;9.29;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
393;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.18;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
394;144963;Drug Discovery Today: Disease Models;journal;17406757;0.177;Q4;28;63;112;2356;34;107;0.3;37.4;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q4); Molecular Medicine (Q4)"
395;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.175;Q3;22;31;98;636;18;98;0.19;20.52;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q3)
396;22205;Saudi Pharmaceutical Journal;journal;13190164;0.174;Q3;57;28;72;739;25;70;0.43;26.39;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
397;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.173;Q3;45;102;267;1470;83;267;0.26;14.41;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
398;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.171;Q4;39;17;44;260;13;44;0.23;15.29;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
399;15842;Journal of Applied Research;journal;1537064X;0.17;Q3;22;38;211;880;85;209;0.43;23.16;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
400;22934;Chinese Pharmaceutical Journal;journal;10012494;0.168;Q3;21;454;1206;3859;194;1206;0.14;8.5;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
401;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.167;Q3;18;25;76;833;14;73;0.16;33.32;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q3)
402;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.167;Q4;19;139;343;3510;81;320;0.2;25.25;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
403;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.166;Q3;14;24;82;547;14;82;0.26;22.79;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3)"
404;110097;Food and Drug Law Journal;journal;1064590X;0.165;Q4;22;30;111;929;34;107;0.32;30.97;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q3); Pharmacology (Q4)"
405;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.164;Q4;24;52;124;754;51;124;0.55;14.5;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q4)
406;23171;Korean Journal of Pharmacognosy;journal;02533073;0.163;Q3;17;56;188;1239;30;188;0.18;22.13;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
407;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.162;Q4;24;80;223;1436;76;165;0.31;17.95;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
408;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.161;Q3;20;19;82;352;8;81;0.1;18.53;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q3)
409;25171;Mycotoxin Research;journal;18671632, 01787888;0.161;Q4;40;43;121;898;28;116;0.12;20.88;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q4); Microbiology (Q4); Toxicology (Q4)"
410;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.16;Q3;13;85;219;729;20;195;0.05;8.58;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
411;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.159;Q3;43;147;305;4643;156;305;0.48;31.59;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
412;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.158;Q4;14;11;65;101;17;65;0.26;9.18;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
413;22908;Chinese Pharmacological Bulletin;journal;10011978;0.157;Q4;17;347;1136;5295;214;1136;0.18;15.26;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q4)
414;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.157;Q4;47;40;96;1102;29;96;0.27;27.55;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
415;67938;Journal of Social and Administrative Pharmacy;journal;02810662;0.156;Q3;20;0;40;0;14;33;0;0;Sweden;Western Europe;Swedish Pharmaceutical Press;1962, 1986-2003;"Leadership and Management (Q3); Pharmaceutical Science (Q3)"
416;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.154;Q3;7;30;84;717;10;84;0.12;23.9;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
417;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.154;Q3;33;22;26;952;23;23;0.88;43.27;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
418;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.154;Q3;17;27;61;553;17;50;0.28;20.48;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
419;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.154;Q4;29;28;116;637;17;115;0.08;22.75;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
420;21142;Pharmaceutisch Weekblad;journal;00316911;0.152;Q4;9;677;1596;996;52;1197;0.04;1.47;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
421;19427;Advances in Pharmacology;journal;15578925, 10543589;0.151;Q4;78;42;54;3296;23;50;0.43;78.48;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4)"
422;130150;Advances in Pharmacy;journal;15323862;0.15;Q3;2;0;25;0;3;16;0.12;0;United States;Northern America;Facts and Comparisons;2005;Pharmaceutical Science (Q3)
423;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.15;Q3;43;60;203;2159;33;192;0.16;35.98;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
424;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.146;Q3;50;169;125;833;44;125;0.27;4.93;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
425;16893;Biogenic Amines;journal;15693910, 01688561;0.145;Q4;15;19;85;479;20;82;0.25;25.21;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
426;145693;Canadian Pharmacists Journal;journal;17151635;0.145;Q3;24;155;408;718;26;261;0.07;4.63;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
427;25197;Revista de Toxicologia (discontinued);journal;02127113;0.144;Q4;11;23;58;570;8;58;0.08;24.78;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
428;86688;Acta Toxicologica;journal;17316383;0.141;Q4;7;17;50;367;7;46;0.12;21.59;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
429;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.141;Q4;13;69;156;762;17;124;0.09;11.04;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
430;63982;Journal of Cannabis Therapeutics;journal;15299775, 15299783;0.14;Q4;16;0;18;0;17;15;0.75;0;United States;Northern America;Haworth Integrative Healing Press;2001-2004;Pharmacology (Q4)
431;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.139;Q4;18;103;92;1780;4;91;0.04;17.28;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
432;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.138;Q4;37;49;92;1301;23;92;0.28;26.55;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
433;20628;Circular Farmaceutica;journal;00097314;0.137;Q4;3;33;128;250;4;113;0.05;7.58;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
434;130006;Medicinal Chemistry Reviews - Online;journal;15672034;0.136;Q4;7;0;46;0;13;46;0.28;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Drug Discovery (Q4); Molecular Medicine (Q4)"
435;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.135;Q3;61;154;53;825;20;51;0.38;5.36;China;Asiatic Region;Zhejiang University Press;2005-2021;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Veterinary (miscellaneous) (Q4)"
436;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.134;Q4;12;69;267;1106;39;265;0.16;16.03;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
437;22338;Hospital Pharmacy;journal;19451253, 00185787;0.134;Q4;24;145;425;2102;67;367;0.16;14.5;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacology (medical) (Q3); Pharmacy (Q3); Pharmacology (Q4)"
438;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.133;Q4;25;14;13;578;2;11;0.15;41.29;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q4); Sports Science (Q4)"
439;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.133;Q3;7;12;57;207;11;52;0.24;17.25;United States;Northern America;Haworth Press Inc.;2003-2008;"Pharmaceutical Science (Q3); Health Policy (Q4); Pharmacology (Q4)"
440;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.132;Q4;11;32;111;1119;22;111;0.23;34.97;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Pharmacology (medical) (Q3); Clinical Psychology (Q4); Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
441;22977;Journal de Pharmacie de Belgique;journal;00472166;0.132;Q4;12;19;57;367;14;57;0.28;19.32;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
442;15892;Journal of Drug Evaluation;journal;14791137;0.13;Q4;4;0;45;0;6;19;0.13;0;United Kingdom;Western Europe;Parthenon Publishing Group;2003-2004;"Pharmacy (Q3); Pharmacology (Q4)"
443;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.128;Q4;46;14;72;344;11;71;0.16;24.57;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q4)
444;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.127;Q4;27;48;168;1279;37;164;0.16;26.65;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
445;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.127;Q4;17;13;77;612;13;70;0.24;47.08;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
446;17716;Quality Assurance Journal;journal;10991786, 10878378;0.127;Q4;9;26;97;222;13;85;0.17;8.54;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
447;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.126;Q4;39;7;64;387;15;64;0.03;55.29;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
448;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.125;Q4;20;27;70;763;19;68;0.21;28.26;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q3); Pharmaceutical Science (Q4)"
449;21716;Pharmazeutische Zeitung;journal;00317136;0.124;Q4;7;464;1385;859;18;710;0.01;1.85;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
450;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.124;Q4;32;457;991;4740;190;991;0.16;10.37;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
451;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.123;Q4;33;52;163;1671;21;163;0.17;32.13;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
452;21077;Pharmaca;journal;00316857;0.123;Q4;5;15;23;334;5;22;0.25;22.27;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
453;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.123;Q4;9;37;69;453;6;69;0.09;12.24;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
454;19700201521;Journal of Chemical and Pharmaceutical Research (discontinued);journal;09757384;0.122;Q4;39;0;1;0;0;1;0;0;India;Asiatic Region;JOCPR;2004, 2011-2016;Pharmaceutical Science (Q4)
455;130031;Journal of Toxicologic Pathology;journal;09149198;0.122;Q4;30;30;65;908;11;65;0.16;30.27;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
456;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.122;Q4;18;36;87;1156;6;83;0.07;32.11;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q4)
457;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.121;Q4;11;20;64;869;7;64;0.05;43.45;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
458;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.121;Q4;34;159;494;3044;38;491;0.08;19.14;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
459;20572;PZ Prisma;journal;09455566;0.121;Q4;5;34;97;669;6;84;0.06;19.68;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
460;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.12;Q4;10;36;84;951;5;83;0.07;26.42;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
461;22514;Japanese Journal of Chemotherapy;journal;13407007;0.118;Q4;12;40;240;726;17;240;0.07;18.15;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
462;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.117;Q4;2;2;3;73;2;3;0;36.5;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
463;144879;Toxicology International;journal;09716580;0.116;Q4;28;19;20;442;3;20;0.15;23.26;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
464;21867;Geneesmiddelenbulletin;journal;03044629;0.115;Q4;7;69;195;225;7;33;0.04;3.26;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
465;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.114;Q4;12;0;0;0;0;0;0;0;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
466;72164;Journal of Infectious Disease Pharmacotherapy;journal;10687777;0.114;Q4;6;0;19;0;3;19;0;0;United States;Northern America;Pharmaceutical Products Press;1996, 1998-1999, 2001-2004;"Microbiology (medical) (Q4); Pharmacology (Q4)"
467;19700175108;Drug Delivery System;journal;18812732, 09135006;0.112;Q4;8;30;118;621;9;118;0.09;20.7;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
468;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.111;Q4;13;36;140;874;11;104;0.07;24.28;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
469;72755;Phytomedica;journal;09723293;0.111;Q4;4;16;54;213;2;54;0;13.31;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
470;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.111;Q4;47;0;2;0;0;2;0;0;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
471;22887;Chinese Journal of Antibiotics;journal;10018689;0.11;Q4;11;189;603;2130;25;594;0.04;11.27;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
472;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.11;Q4;15;100;331;1954;24;331;0.05;19.54;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
473;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.11;Q4;3;85;301;191;4;253;0.02;2.25;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
474;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.11;Q4;4;28;201;744;1;200;0;26.57;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
475;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.11;Q4;23;12;18;340;3;17;0.17;28.33;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q4); Health, Toxicology and Mutagenesis (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
476;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.109;Q4;21;0;34;0;5;32;0.17;0;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q4); Molecular Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
477;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.108;Q4;28;15;57;0;12;57;0.24;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
478;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.108;Q4;42;62;53;434;5;53;0.09;7;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q4)
479;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.107;Q4;5;76;198;344;5;175;0.03;4.53;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
480;21329;European Journal of Herbal Medicine;journal;13524755;0.107;Q4;2;0;8;0;0;3;0;0;United Kingdom;Western Europe;National Institute of Medical Herbalists Ltd;2001-2004;Pharmacology (Q4)
481;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.107;Q4;16;81;233;1363;16;228;0.09;16.83;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
482;22979;Journal of Applied Therapeutic Research;journal;10292659;0.107;Q4;8;5;47;96;8;47;0.24;19.2;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
483;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.107;Q4;19;42;94;1075;10;71;0.07;25.6;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
484;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.106;Q4;11;11;49;181;5;36;0.11;16.45;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
485;21814;Research Communications in Pharmacology and Toxicology;journal;10871101;0.106;Q4;7;0;14;0;3;14;0;0;United States;Northern America;PJD Publications Ltd;1997-2003;"Pharmacology (Q4); Toxicology (Q4)"
486;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0.105;Q4;6;0;30;0;6;29;0.2;0;France;Western Europe;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
487;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.105;Q4;5;17;89;725;3;89;0.04;42.65;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
488;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.105;Q4;7;77;157;712;4;128;0.03;9.25;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
489;21823;Pharmacia;journal;04280296;0.105;Q4;16;21;98;320;5;98;0.06;15.24;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
490;69108;Chemotherapie Journal, Supplement;journal;09446486;0.104;Q4;6;0;6;0;0;5;0;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1996-1997, 1999-2003;"Microbiology (medical) (Q4); Pharmacology (Q4)"
491;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.104;-;12;2;5;12;0;5;0;6;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
492;21866;Gazi Universitesi Eczacilik Fakultesi Dergisi;journal;10159592;0.104;Q4;8;0;14;0;2;14;0;0;Turkey;Middle East;Gazi Universitesi;1984-2003;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
493;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.104;Q4;52;41;8;21;0;6;0;0.51;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
494;58808;Pharmaceutical Care and Research;journal;16712838;0.104;Q4;8;100;219;820;3;216;0.01;8.2;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
495;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.103;Q4;3;15;39;200;1;37;0.04;13.33;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
496;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.103;-;31;64;161;1120;23;145;0.1;17.5;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
497;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.103;Q4;8;0;31;0;1;28;0.07;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
498;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.102;Q4;25;8;12;596;0;11;0;74.5;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
499;21238;Drug Topics;journal;19378157, 00126616;0.102;Q4;8;453;1574;43;17;1389;0.01;0.09;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
500;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0.102;Q4;0;15;28;179;0;10;0;11.93;Netherlands;Western Europe;;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
501;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
502;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.102;Q4;9;0;11;0;0;11;0;0;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
503;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.102;Q4;5;10;50;225;1;50;0;22.5;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
504;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.102;Q4;6;43;122;199;8;97;0.06;4.63;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q4); Pharmaceutical Science (Q4)"
505;20543;Pharmacometrics;journal;03008533;0.102;Q4;6;0;57;0;7;57;0.09;0;Japan;Asiatic Region;Japanese Society of Pharmacometrics;1973-2004, 2009-2012;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
506;25196;Revista Brasileira de Toxicologia;journal;14152983;0.102;Q4;7;12;38;464;2;35;0.05;38.67;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
507;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.102;Q4;14;24;9;316;0;9;0;13.17;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
508;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.102;Q4;9;31;98;725;3;77;0.03;23.39;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
509;5800207507;Side Effects of Drugs Annual;book series;03786080;0.102;Q4;6;0;153;0;5;104;0.04;0;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
510;145000;Signal;journal;14719967;0.102;Q4;1;7;22;192;0;10;0;27.43;United Kingdom;Western Europe;Adis International Ltd;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
511;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.101;Q4;3;36;37;117;0;32;0;3.25;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
512;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.101;Q4;7;6;18;235;0;18;0;39.17;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
513;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.101;Q4;6;51;112;73;4;112;0.04;1.43;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
514;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.101;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
515;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.101;Q4;34;23;41;0;1;41;0;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
516;20778;EOS Rivista di Immunologia ed Immunofarmacologia;journal;03926699;0.101;Q4;5;0;25;0;0;25;0;0;Italy;Western Europe;Sigma-Tau SpA;1983-2001, 2003-2004;"Immunology (Q4); Pharmacology (Q4)"
517;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;9;0;17;0;0;17;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
518;19700180822;Immunotoxicology of Drugs and Chemicals: an Experimental and Clinical Approach;book series;18739822;0.101;Q4;2;0;17;0;0;16;0;0;Netherlands;Western Europe;Elsevier;2004;"Immunology (Q4); Toxicology (Q4)"
519;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.101;Q4;9;17;18;224;0;14;0;13.18;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
520;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;7;269;243;2199;3;243;0.01;8.17;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
521;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.101;Q4;6;0;25;0;0;25;0;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
522;130170;Phytotherapie;journal;17652847, 16248597;0.101;Q4;18;43;57;660;1;32;0.02;15.35;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
523;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.101;Q4;2;0;37;0;1;30;0.03;0;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
524;19408;Actualites Pharmaceutiques;journal;05153700;0.1;Q4;5;157;490;145;1;310;0;0.92;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
525;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.1;Q4;14;32;81;383;1;80;0.01;11.97;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
526;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;15;79;273;0;70;0;18.2;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
527;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.1;Q4;35;108;267;1190;2;212;0.01;11.02;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
528;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.1;Q4;10;10;39;790;1;37;0.03;79;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
529;80593;Journal of Medicinal Plants;journal;16840240;0.1;Q4;23;44;81;942;1;81;0.01;21.41;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
530;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.1;Q4;10;0;61;0;0;60;0;0;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
531;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.1;Q4;46;75;259;1250;64;245;0.17;16.67;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
532;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;;-;15;6;0;761;0;0;0;126.83;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis; Pharmacology; Toxicology"
533;19700180757;Advances in Phytomedicine;book series;1572557X;;-;13;43;0;3377;0;0;0;78.53;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery; Plant Science"
534;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;;-;48;53;0;1224;0;0;0;23.09;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine; Drug Discovery; Medicine (miscellaneous)"
535;6400153120;Chinese Medicine;journal;17498546;;-;45;4;0;235;0;0;0;58.75;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine; Pharmacology"
536;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;;-;17;241;0;2145;0;0;0;8.9;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine; Drug Discovery; Pharmaceutical Science; Pharmacology (medical)"
537;4700152609;Current Computer-Aided Drug Design;journal;15734099;;-;31;28;0;2884;0;0;0;103;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery; Medicine (miscellaneous); Molecular Medicine"
538;5800173386;Current Drug Safety;journal;15748863;;-;37;33;0;2335;0;0;0;70.76;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology; Pharmacology (medical); Toxicology"
539;4700152607;Current Enzyme Inhibition;journal;15734080;;-;18;29;0;4245;0;0;0;146.38;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry; Drug Discovery; Molecular Medicine"
540;4700152612;Current Nanoscience;journal;15734137;;-;47;35;0;2729;0;0;0;77.97;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Bioengineering; Biomedical Engineering; Biotechnology; Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
541;4700152426;Current Pharmaceutical Analysis;journal;15734129;;-;25;32;0;3266;0;0;0;102.06;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Biochemistry; Biophysics; Molecular Medicine; Pharmaceutical Science"
542;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;28;0;2804;0;0;0;100.14;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
543;9100153105;Current Topics in Pharmacology;journal;09724559;;-;6;18;0;1285;0;0;0;71.39;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology; Pharmacology (medical)"
544;4700152278;Drugs in Context;journal;17404398, 17451981;;-;26;48;0;1289;0;0;0;26.85;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine; Pharmacology"
545;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;14;47;516;47;46;0.88;36.86;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
546;5100154302;European Biotechnology Science and Industry News;journal;16188276;;-;2;70;0;15;0;0;0;0.21;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology; Drug Discovery"
547;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;;-;68;65;0;4028;0;0;0;61.97;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery
548;5200152843;Farmaceutico Hospitales;journal;02144697;;-;3;8;0;80;0;0;0;10;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
549;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;;-;9;18;0;1416;0;0;0;78.67;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Drug Discovery; Molecular Medicine; Pharmaceutical Science"
550;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;;-;7;27;0;4364;0;0;0;161.63;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery; Molecular Medicine; Organic Chemistry"
551;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;;-;51;32;0;2799;0;0;0;87.47;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Immunology; Immunology and Allergy; Medicine (miscellaneous); Pharmacology"
552;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;;-;145;59;0;2705;0;0;0;45.85;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering; Biomaterials; Biophysics; Drug Discovery; Medicine (miscellaneous); Nanoscience and Nanotechnology; Organic Chemistry"
553;4000151610;International Journal of Neuroprotection and Neuroregeneration;journal;17451183, 17451191;;-;5;26;0;1066;0;0;0;41;United Kingdom;Western Europe;RPA Publishers.;2006-2008;"Neurology (clinical); Pharmacology"
554;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;;-;11;115;0;879;0;0;0;7.64;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Medicine (miscellaneous); Pharmaceutical Science; Pharmacology (medical); Pharmacology (nursing); Pharmacy"
555;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;;-;39;128;0;3397;0;0;0;26.54;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology
556;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;46;130;1001;28;120;0.19;21.76;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
557;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;;-;21;31;0;1139;0;0;0;36.74;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology
558;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;13;59;173;3;57;0;13.31;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
559;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;;-;77;40;0;3423;0;0;0;85.58;United States;Northern America;Springer New York;2006-2021;"Immunology; Immunology and Allergy; Neuroscience (miscellaneous); Pharmacology"
560;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;;-;42;28;0;976;0;0;0;34.86;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health; Safety Research; Toxicology"
561;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;;-;31;10;0;195;0;0;0;19.5;United States;Northern America;Springer New York;2006-2021;"Drug Discovery; Pharmaceutical Science"
562;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;;-;32;60;0;1258;0;0;0;20.97;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Animal Science and Zoology; Infectious Diseases; Parasitology; Toxicology"
563;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;100;248;2474;54;248;0.19;24.74;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
564;13637;Manufacturing Chemist;trade journal;02624230;;-;6;10;0;8;0;0;0;0.8;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science
565;4200151509;Molecular Diagnosis and Therapy;journal;11771062;;-;47;43;0;2421;0;0;0;56.3;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Genetics; Medicine (miscellaneous); Molecular Medicine; Pharmacology"
566;4700152457;Nano Today;journal;17480132;;-;155;24;0;984;0;0;0;41;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering; Biomedical Engineering; Biotechnology; Materials Science (miscellaneous); Medicine (miscellaneous); Nanoscience and Nanotechnology; Pharmaceutical Science"
567;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;;-;14;41;0;646;0;0;0;15.76;Germany;Western Europe;Springer Verlag;2006-2008;"Biotechnology; Chemistry (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
568;17700155034;Natural Product Communications;journal;15559475, 1934578X;;-;50;167;0;5687;0;0;0;34.05;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine; Drug Discovery; Medicine (miscellaneous); Pharmacology; Plant Science"
569;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;14;1;9;0;1;9;0.13;0;United States;Northern America;"John Wiley &amp; Sons Inc.";2018-2021;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
570;4500151530;Personalized Medicine;journal;17410541;;-;33;42;0;1935;0;0;0;46.07;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous); Molecular Medicine; Pharmacology"
571;5000158120;Pharmacy News;journal;1448207X;;-;1;72;0;2;0;0;0;0.03;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science; Pharmacology (nursing)"
572;4700152701;Pharmacy Practice;journal;1885642X, 18863655;;-;28;33;0;759;0;0;0;23;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmaceutical Science; Pharmacy"
573;5200152604;Pharma Times;journal;00316849;;-;12;25;0;265;0;0;0;10.6;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
574;4700152848;PPAR Research;journal;16874757, 16874765;;-;52;12;0;553;0;0;0;46.08;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery; Pharmacology (medical)"
575;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;30;0;2647;0;0;0;88.23;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
576;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;;-;46;27;0;3398;0;0;0;125.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Cancer Research; Drug Discovery; Medicine (miscellaneous); Oncology; Pharmacology (medical)"
577;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;;-;28;27;0;2843;0;0;0;105.3;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine; Drug Discovery; Pharmacology (medical)"
578;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;;-;34;25;0;3055;0;0;0;122.2;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Drug Discovery; Pharmacology (medical); Psychiatry and Mental Health"
579;5800173387;Reviews on Recent Clinical Trials;journal;15748871;;-;32;31;0;2212;0;0;0;71.35;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous); Pharmacology"
580;4100151616;Supportive Cancer Therapy;journal;15432912;;-;14;38;0;1150;0;0;0;30.26;United States;Northern America;Cancer Information Group, LP;2006-2007;"Cancer Research; Oncology; Pharmacology"
581;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;;-;59;47;0;2919;0;0;0;62.11;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Chemical Health and Safety; Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous); Safety Research"
582;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;;-;16;15;0;320;0;0;0;21.33;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Molecular Medicine; Pharmaceutical Science"
